Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
Published Online: 2015-03-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Ben Heijmen•Emile van Lin•Erik Schimmel•Floris Pos•Hanja de Jager•Luca Incrocci•Maarten Dirkx•Peter Paul van der Toorn•Shafak Aluwini•Stijn Krol•Wendimagegn Ghidey Alemayehu
